DTE
31
2
F
47
4
CRM
32
3
SBUX
33
2
NDAQ
60
4
ZION
56
3
FOX
59
2
LYB
11
7
A
30
4
ISRG
62
2
PRU
47
2
FITB
50
2
BEN
18
4
PDCO
57
2
CB
47
3
SYK
37
2
AAP
14
2
MAS
56
2
MDLZ
57
7
HAS
45
2
DTE
31
2
F
47
4
CRM
32
3
SBUX
33
2
NDAQ
60
4
ZION
56
3
FOX
59
2
LYB
11
7
A
30
4
ISRG
62
2
PRU
47
2
FITB
50
2
BEN
18
4
PDCO
57
2
CB
47
3
SYK
37
2
AAP
14
2
MAS
56
2
MDLZ
57
7
HAS
45
2
Financhill
Back

Insmed Stock Predictions

He's already IPO'd once - this time's different

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
43

INSM
Insmed

Last Price:
$71.01
Seasonality Move:
19.62%

7 Day Trial

ALL ACCESS PASS

$ 7

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Insmed Stock Forecast

  • Over the next 52 weeks, Insmed has on average historically risen by 23.1% based on the past 24 years of stock performance.
  • Insmed has risen higher in 13 of those 24 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.17%
  • Is Insmed Stock Undervalued?
    The current Insmed [INSM] share price is $68.57. The Score for INSM is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • INSM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Insmed Stock Go Up Next Year?

  • Over the next 52 weeks, Insmed has on average historically risen by 23.1% based on the past 24 years of stock performance.

Insmed Stock Rating

Sell
43
Insmed (INSM) is a Sell

Is Insmed overpriced?

  • Insmed has risen higher in 13 of those 24 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.17%

Insmed Stock Price History

Is INSM stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INSM is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
insmed.com

52-Week Data

52-Week High:
84.91
52-Week Low:
21.92

Prediction Charts

Market Cap:
12.4B
Price in USD:
68.57
Volume:
1.8M
Beta:
1.52

Technical Analysis

SMA50:
76.70
SMA100:
74.38
SMA200:
73.63
52-Wk Change:
140.09%

Stock Predictions

  • Is Insmed stock public?
    Yes, Insmed is a publicly traded company.
  • What is the Insmed stock quote today?
    The Insmed stock price is 68.57 USD today.
  • How to buy Insmed stock online?
    You can buy Insmed shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-25 79.94 78.54 80.00 77.82
Mar-26 78.17 76.57 78.79 76.06
Mar-27 76.64 77.69 79.12 76.05
Mar-28 77.67 77.99 78.05 76.28
Mar-31 76.24 76.29 76.70 73.81
Apr-1 75.35 72.00 75.65 71.94
Apr-2 71.71 73.44 73.45 70.30
Apr-3 71.50 73.33 74.31 71.05
Apr-4 70.43 69.18 72.50 67.80
Apr-7 66.21 68.09 70.52 64.29
Apr-8 69.88 65.00 70.56 64.19
Apr-9 63.51 67.64 68.70 60.40
Apr-10 65.73 64.81 67.19 61.48
Apr-11 64.98 68.57 68.63 64.35

Insmed Earnings

Insmed Earnings Report: Per Share Insmed Earnings Q1 Q2 Q3 and Q4 last year and next year.

Insmed Forecast Revenue Growth

Insmed Stock Analysis: Historical quarterly revenues per share for Insmed and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $1.79 per share.

* Insmed stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.